[
  {
    "ts": "2025-11-25T03:01:25+00:00",
    "headline": "If You Invested $10K In Johnson & Johnson Stock 10 Years Ago, How Much Would You Have Now?",
    "summary": "Johnson & Johnson (NYSE:JNJ) is a global healthcare company that develops, manufactures, and sells pharmaceutical products and medical devices. It is set to report its Q4 2025 earnings on Jan. 21. Wall Street analysts expect the company to post EPS of ...",
    "url": "https://finance.yahoo.com/news/invested-10k-johnson-johnson-stock-030125392.html",
    "source": "Benzinga",
    "provider": "yfinance",
    "raw": {
      "id": "ec84e0e2-02e6-3503-8465-84193861e8db",
      "content": {
        "id": "ec84e0e2-02e6-3503-8465-84193861e8db",
        "contentType": "STORY",
        "title": "If You Invested $10K In Johnson & Johnson Stock 10 Years Ago, How Much Would You Have Now?",
        "description": "",
        "summary": "Johnson & Johnson (NYSE:JNJ) is a global healthcare company that develops, manufactures, and sells pharmaceutical products and medical devices. It is set to report its Q4 2025 earnings on Jan. 21. Wall Street analysts expect the company to post EPS of ...",
        "pubDate": "2025-11-25T03:01:25Z",
        "displayTime": "2025-11-25T03:01:25Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/benzinga_79/5c75f5f8f854b8b5abd206342c36cd1a",
          "originalWidth": 720,
          "originalHeight": 480,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Xysd8yXM.qIX4ypgMVrXig--~B/aD00ODA7dz03MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/benzinga_79/5c75f5f8f854b8b5abd206342c36cd1a.cf.webp",
              "width": 720,
              "height": 480,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/JgNVROaeAlVS3L2H7bfd1A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/benzinga_79/5c75f5f8f854b8b5abd206342c36cd1a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Benzinga",
          "url": "https://www.benzinga.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/invested-10k-johnson-johnson-stock-030125392.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/invested-10k-johnson-johnson-stock-030125392.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-25T12:24:00+00:00",
    "headline": "J&J Up Around 17% in 3 Months: Should You Buy, Sell or Hold the Stock?",
    "summary": "J&J's 16.7% rise reflects stronger sales guidance, rapid pipeline advances and improving MedTech momentum amid a recovering sector.",
    "url": "https://finance.yahoo.com/news/j-j-around-17-3-122400598.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "8392a715-958e-3f0a-b30d-1fda5fff8259",
      "content": {
        "id": "8392a715-958e-3f0a-b30d-1fda5fff8259",
        "contentType": "STORY",
        "title": "J&J Up Around 17% in 3 Months: Should You Buy, Sell or Hold the Stock?",
        "description": "",
        "summary": "J&J's 16.7% rise reflects stronger sales guidance, rapid pipeline advances and improving MedTech momentum amid a recovering sector.",
        "pubDate": "2025-11-25T12:24:00Z",
        "displayTime": "2025-11-25T12:24:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/9883d206905e7516b2353476e213e60c",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/WtA490SSyXq.BB5XEEYFSg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9883d206905e7516b2353476e213e60c.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/BdQSUWaJAMCKg7gp75c9jQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9883d206905e7516b2353476e213e60c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/j-j-around-17-3-122400598.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/j-j-around-17-3-122400598.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NVO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-25T08:00:00+00:00",
    "headline": "4 takeaways from pharma’s manufacturing boom",
    "summary": "As pharma’s U.S. facility investments top $370 billion over the next five years, there are a few things to keep in mind, according to construction experts.",
    "url": "https://www.pharmavoice.com/news/pharma-manufacturing-boom-takeaways/806347/",
    "source": "Pharma Voice",
    "provider": "yfinance",
    "raw": {
      "id": "7eddfa3d-98b0-310a-9cbc-1410d8520d34",
      "content": {
        "id": "7eddfa3d-98b0-310a-9cbc-1410d8520d34",
        "contentType": "STORY",
        "title": "4 takeaways from pharma’s manufacturing boom",
        "description": "",
        "summary": "As pharma’s U.S. facility investments top $370 billion over the next five years, there are a few things to keep in mind, according to construction experts.",
        "pubDate": "2025-11-25T08:00:00Z",
        "displayTime": "2025-11-25T08:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharma_voice_330/55be0bf0554fdae9f49f7f23956f3bc7",
          "originalWidth": 1600,
          "originalHeight": 900,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/u9czpu1ZeOo83B1Iq3OOWQ--~B/aD05MDA7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharma_voice_330/55be0bf0554fdae9f49f7f23956f3bc7.cf.webp",
              "width": 1600,
              "height": 900,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/gTwKjxJU4WV1UEhIzppTlA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharma_voice_330/55be0bf0554fdae9f49f7f23956f3bc7.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharma Voice",
          "url": "https://www.pharmavoice.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmavoice.com/news/pharma-manufacturing-boom-takeaways/806347/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/4-takeaways-pharma-manufacturing-boom-080000234.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NVS"
            },
            {
              "symbol": "RHHBF"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-25T11:30:00+00:00",
    "headline": "Bayer Resurrects Scrapped Blood-Thinning Drug as Breakthrough Stroke Treatment",
    "summary": "The trial proved so successful that Bayer plans to reach out to regulators in preparation for submitting the drug candidate for approval.",
    "url": "https://www.thedailyupside.com/industries/healthcare/bayer-resurrects-scrapped-blood-thinning-drug-as-breakthrough-stroke-treatment/",
    "source": "The Daily Upside",
    "provider": "yfinance",
    "raw": {
      "id": "96d76b9f-aa4b-32bc-9911-9f2034cf7070",
      "content": {
        "id": "96d76b9f-aa4b-32bc-9911-9f2034cf7070",
        "contentType": "STORY",
        "title": "Bayer Resurrects Scrapped Blood-Thinning Drug as Breakthrough Stroke Treatment",
        "description": "",
        "summary": "The trial proved so successful that Bayer plans to reach out to regulators in preparation for submitting the drug candidate for approval.",
        "pubDate": "2025-11-25T11:30:00Z",
        "displayTime": "2025-11-25T11:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/the_daily_upside_435/6a39d535f2e4ef9e6c7effc2d30340df",
          "originalWidth": 1600,
          "originalHeight": 901,
          "caption": "Photo of a Bayer AG office building.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/oL0ICHfGKa95jbg4R1O0yQ--~B/aD05MDE7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/the_daily_upside_435/6a39d535f2e4ef9e6c7effc2d30340df.cf.webp",
              "width": 1600,
              "height": 901,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6BKm02o65HZcR_4Zo4I8lQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/the_daily_upside_435/6a39d535f2e4ef9e6c7effc2d30340df.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Daily Upside",
          "url": "http://thedailyupside.com/"
        },
        "canonicalUrl": {
          "url": "https://www.thedailyupside.com/industries/healthcare/bayer-resurrects-scrapped-blood-thinning-drug-as-breakthrough-stroke-treatment/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bayer-resurrects-scrapped-blood-thinning-113000634.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BAYRY"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-25T19:01:00+00:00",
    "headline": "BMY Wins EC Nod for Label Expansion of CAR T Cell Therapy Breyanzi",
    "summary": "Bristol Myers wins EC approval to expand Breyanzi's label, adding MCL patients to its growing roster of European CAR-T indications.",
    "url": "https://finance.yahoo.com/news/bmy-wins-ec-nod-label-190100239.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "27a7ca5f-cfbc-373f-8ac9-e2223f6fdae7",
      "content": {
        "id": "27a7ca5f-cfbc-373f-8ac9-e2223f6fdae7",
        "contentType": "STORY",
        "title": "BMY Wins EC Nod for Label Expansion of CAR T Cell Therapy Breyanzi",
        "description": "",
        "summary": "Bristol Myers wins EC approval to expand Breyanzi's label, adding MCL patients to its growing roster of European CAR-T indications.",
        "pubDate": "2025-11-25T19:01:00Z",
        "displayTime": "2025-11-25T19:01:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/52b6d392b63705aefb517365eab38a95",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AZ1NFKr1Arip4UWINeWStw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/52b6d392b63705aefb517365eab38a95.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zL5_evNVQm1N5N.bc6WldQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/52b6d392b63705aefb517365eab38a95.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bmy-wins-ec-nod-label-190100239.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bmy-wins-ec-nod-label-190100239.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "BAYRY"
            },
            {
              "symbol": "BAYZF"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]